Insights
Recon takes an analytical look behind select developments in healthcare
Keep up with Recon Strategy Insights
Get an email each time we publish a new article
Search
- By Marc Herant
Continued progress in multiple myeloma
About 25,000 patients are diagnosed with multiple myeloma yearly in the US. Despite being initially treatable, typically this disease is ultimately lethal. Follo…
- By Marc Herant
Taking a page from HIV to build a response to opioid abuse
A couple of perspectives on the challenges of treating individuals who suffer from opioid dependence. The first highlights the importance of …
- By Marc Herant
There is such a thing as too much hygiene
The prevalence of asthma in children has increased dramatically over the last few decades. Observational studies have shown that children in “dirty” environme…
- By Tory Wolff
Summary
Cheap home devices are starting to generate a flood of high frequency, low latency biometric data, much of it of uncertain clinical value
This uncertainty makes designing the service model di…
- By Marc Herant
Adaptive clinical trials slowly coming of age
In an adaptive clinical trial, the protocol of the trial is allowed to change in a pre-specified manner during the study based on on-going study events. …
- By Marc Herant
Disappointing interim results from two ACA experiments
Two papers reporting results from ACA experiments – the Comprehensive Primary Care (CPC) Initiative in which primary practices were incentivized …
- By Tory Wolff
Summary
Livongo is marrying a cellular-enabled glucometer and a data cloud with patient engagement services to help manage sugar levels
Glucometer incumbents could match Livongo’s technology but will…
- By Marc Herant
It is a long-standing hypothesis shared by many providers that community-based interventions that improve primary care could lead to overall healthcare savings by preventing (or delaying) the occurren…